Julie Costello
Monroe,GA
Summary
Clinical Research Coordinator with 15 years of demonstrated history of working in clinical research, management support, regulatory compliance, and coordination of study related tasks in multi-faceted clinical trials looking for opportunities to expand knowledge and experience within Emory University. Extremely focused with a competitive attitude. Desires a position in Research Coordination, Management and Monitoring. Dedicated, hard-working, reliable, and detail-oriented professional who always delivers exceptional service. Talents include in-depth knowledge of ICH guidelines, SAE reporting, GCP auditing and creating/maintaining databases and reports. Integral team-player with excellent communication skills and expertise in liaising between different departments. Currently works collaboratively with Investigators and Research Program Managers at Emory University and Atlanta VAMC in the infectious disease research program to provide deliverables related to clinical research project activities.
Overview
24
24
years of professional experience
1
1
Certification
Work History
Clinical Research Coordinator
FAVER
Atlanta, GA
05.2016 - Current
- Identifying, recruiting, and screening potential study participants, and conducting patient and family education accordingly.
- Performing patient evaluations, administering medications and research instruments.
- Making referrals to in-house or community professionals serves as a clinical resource.
- Collecting and documenting data, assisting in developing data collection systems and compiling reports.
- Collecting specimens, to include phlebotomy, processing and preparation for shipping, ECG tracings and vital signs.
- Coordinating, implementing, and evaluating clinical research trials, studies and projects to improve and advance clinical research within the organization.
- Providing direction in the development of research protocols.
- Providing leadership or assistance in identifying and writing study materials, brochures, and correspondence.
- Providing direction in auditing and monitoring activities.
- Collaborating with multidisciplinary researchers to establish research programs that integrate new advances in clinical trials management.
- Conducting on-going training of clinical trials staff, providing updated information on internal processes and resources and external benchmarks.
- Ensuring compliance with research and health care regulatory requirements and guidelines.
- Performing related responsibilities as required.
- Overall coordination and facilitation of clinical study activities.
- Collects, records, maintains all participant data and specimen, which may include phlebotomy, lab processing and shipping 12 lead ECG NIHSS certification.
- Managing patient / study participant recruitment, screening, follow-up visits, education, and evaluations.
- Report adverse events to governing agencies and sponsors as required by protocol and regulations.
- Responsible for administrative activities associated with the study, including interacting with regulatory organizations, sponsors, and contract research organizations.
- Assisted with scheduling and performance of procedures and research tests designated by protocol, query response, reviewing charts from database for potential subjects, and attending investigator/coordinator meetings for the clinical trials while assuring adherence to SOP’s, Good Clinical Practice (GCP) and FDA regulations.
- Maintained activities pertaining to conducting clinical trials and managed research studies data, documents, and forms.
- Provided guidance and pertinent information to the team members regarding the study.
- Infectious Diseases Team ( COVID-19, Long COVID, HIV+ Population, Cardiology, Diabetes, Pulmonary clinical and observational trials)
Clinical Research Coordinator
FAVER
Atlanta, GA
05.2016 - Current
- Identifying, recruiting, and screening potential study participants, and conducting patient and family education accordingly.
- Performing patient evaluations, administering medications and research instruments.
- Making referrals to in-house or community professionals serves as a clinical resource.
- Collecting and documenting data, assisting in developing data collection systems and compiling reports.
- Collecting specimens, to include phlebotomy, processing and preparation for shipping, ECG tracings and vital signs.
- Coordinating, implementing, and evaluating clinical research trials, studies and projects to improve and advance clinical research within the organization.
- Providing direction in the development of research protocols.
- Providing leadership or assistance in identifying and writing study materials, brochures, and correspondence.
- Providing direction in auditing and monitoring activities.
- Collaborating with multidisciplinary researchers to establish research programs that integrate new advances in clinical trials management.
- Conducting on-going training of clinical trials staff, providing updated information on internal processes and resources and external benchmarks.
- Ensuring compliance with research and health care regulatory requirements and guidelines.
- Performing related responsibilities as required.
- Overall coordination and facilitation of clinical study activities.
- Collects, records, maintains all participant data and specimen, which may include phlebotomy, lab processing and shipping 12 lead ECG NIHSS certification.
- Managing patient / study participant recruitment, screening, follow-up visits, education, and evaluations.
- Report adverse events to governing agencies and sponsors as required by protocol and regulations.
- Responsible for administrative activities associated with the study, including interacting with regulatory organizations, sponsors, and contract research organizations.
- Assisted with scheduling and performance of procedures and research tests designated by protocol, query response, reviewing charts from database for potential subjects, and attending investigator/coordinator meetings for the clinical trials while assuring adherence to SOP’s, Good Clinical Practice (GCP) and FDA regulations.
- Maintained activities pertaining to conducting clinical trials and managed research studies data, documents, and forms.
- Provided guidance and pertinent information to the team members regarding the study.
- Infectious Diseases Team ( COVID-19, Long COVID, HIV+ Population, Cardiology, Diabetes, Pulmonary clinical and observational trials)
Clinical Research Coordinator
In-Quest Medical Research, LLC
Norcross, Georgia
11.2015 - 04.2016
- Responsible for negotiating budgets and contracts with Pharmaceutical Companies.
- Recruited adult patients from our practice to enter our Clinical Studies.
- Thoroughly discussed the consent procedures with each patient. This included the purpose of the study, possible side effects to the medication, the medication being given as well as its dosage, the reason the study was being conducted as well as the length of the study.
- Always conducted the clinical studies under Good Clinical Practice.
- Developed and maintained source documents.
- Kept a very detailed document of each visit for each patient.
- Entered all data from the visit into a Case Report Form via the internet which gave the Pharmaceutical Companies the information to be obtained.
- Conducted electrocardiograms, collected vital signs, medical history.
- Maintained detailed records of any side effects the patient had during the treatment as well as any new medications the patient may have started.
- Constant communication with all Pharmaceutical Companies.
- Worked closely with CRA’s from pharmaceutical companies ensuring that all work was conducted according to protocol.
- Managed 4-6 Hepatitis B and Hepatitis C studies at a time which would include anywhere from 3-10 patients in each study.
Clinical Research Coordinator
In-Quest Medical Research, LLC
Norcross, Georgia
11.2015 - 04.2016
- Responsible for negotiating budgets and contracts with Pharmaceutical Companies.
- Recruited adult patients from our practice to enter our Clinical Studies.
- Thoroughly discussed the consent procedures with each patient. This included the purpose of the study, possible side effects to the medication, the medication being given as well as its dosage, the reason the study was being conducted as well as the length of the study.
- Always conducted the clinical studies under Good Clinical Practice.
- Developed and maintained source documents.
- Kept a very detailed document of each visit for each patient.
- Entered all data from the visit into a Case Report Form via the internet which gave the Pharmaceutical Companies the information to be obtained.
- Conducted electrocardiograms, collected vital signs, medical history.
- Maintained detailed records of any side effects the patient had during the treatment as well as any new medications the patient may have started.
- Constant communication with all Pharmaceutical Companies.
- Worked closely with CRA’s from pharmaceutical companies ensuring that all work was conducted according to protocol.
- Managed 4-6 Hepatitis B and Hepatitis C studies at a time which would include anywhere from 3-10 patients in each study.
Clinical Research Coordinator
Child Neurology Associates, PC
Atlanta, GA
07.2004 - 12.2006
- Worked with children who suffered from Migraines, Seizures, ADD, ADHD, Narcolepsy as well as other neurological issues through Clinical Research Studies under the supervision of a Physician.
- Developed, conducted, and facilitated research protocols.
- Supported investigators in writing study protocols.
- Performed participant screening, enrollment, study activities, and communication.
- Coordinated study visits and procedures, including specimen acquisition, transport, documentation, and shipment.
- Maintained equipment and supply resources for research studies.
- Obtained informed consent by following policy, procedure, and regulatory requirements.
- Scheduled study-specific visits in conjunction with ancillary departments.
- Completed data management activities.
- Assisted in the development and completion of source documents and case report forms.
- Completed data entry and ensured data integrity.
- Directed patient interaction to conduct research protocols.
- Administered various research surveys in accordance with research study requirements.
- Completed research-only testing as required and applicable per study and system requirements, including electrocardiograms.
- Provided research study education to participants as part of a study protocol.
- Completed documentation as needed within the medical record.
- Monitored compliance throughout all study activities and engaged compliance oversight as needed.
Clinical Research Coordinator
Child Neurology Associates, PC
Atlanta, GA
07.2004 - 12.2006
- Worked with children who suffered from Migraines, Seizures, ADD, ADHD, Narcolepsy as well as other neurological issues through Clinical Research Studies under the supervision of a Physician.
- Developed, conducted, and facilitated research protocols.
- Supported investigators in writing study protocols.
- Performed participant screening, enrollment, study activities, and communication.
- Coordinated study visits and procedures, including specimen acquisition, transport, documentation, and shipment.
- Maintained equipment and supply resources for research studies.
- Obtained informed consent by following policy, procedure, and regulatory requirements.
- Scheduled study-specific visits in conjunction with ancillary departments.
- Completed data management activities.
- Assisted in the development and completion of source documents and case report forms.
- Completed data entry and ensured data integrity.
- Directed patient interaction to conduct research protocols.
- Administered various research surveys in accordance with research study requirements.
- Completed research-only testing as required and applicable per study and system requirements, including electrocardiograms.
- Provided research study education to participants as part of a study protocol.
- Completed documentation as needed within the medical record.
- Monitored compliance throughout all study activities and engaged compliance oversight as needed.
Scheduling/Medical Assistant
Child Neurology Associates, PC
Atlanta, GA
07.2002 - 07.2004
- Maintained careful records and documentation of communication regarding patient progress and medication changes.
- Secure patient information and maintain patient confidence by completing and safeguarding medical records; completing diagnostic coding and procedure coding; keeping patient information confidential.
- Prioritized daily and handled an excess of 30+ call per day for 2 Pediatric Neurologists and 1 Nurse Practitioner regarding medication refills, medication changes and any current issues that were going on with their patients.
- Built positive relationships both with parents and their children.
- Completed letters of medical necessity as well as other forms the patients needed.
- Maintained constant communication with Physicians and Nurse Practitioners.
Education
Bachelor of Arts - Sociology, Psychology
Piedmont College
Demorest, GA01.1998
Skills
- RECRUITMENT AND SCREENING
- PROJECT MANAGEMENT
- DATA ENTRY
- STUDY PROTOCOL COMPLIANCE
- GOOD CLINICAL PRACTICE
- ANALYTICAL METHODS
- PHLEBOTOMY
- DATA COLLECTION
- DATA ANALYSIS
- REDCAP
- CLINICAL TRIALS
- REGULATORY DOCUMENTS
- ORGANIZATIONAL DEVELOPMENT
- TRAINING OF STAFF
- QUALITY ASSURANCE
- IRB ADMINISTRATION
- CASE REPORT DEVELOPMENT
- HIPAA COMPLIANCE
- PROJECT PLANNING
- PHLEBOTOMY CERTIFIED
- BASIC LIFE SUPPORT (BLS) CERTIFIED – AMERICAN RED CROSS
Certification
- Good Clinical Practice (GCP), 2025-10-26
- Atlanta VA Human Research Protections Coursework, 2025-10-26
- Shipping and Transport of Biological Materials, 2024-10-30
- Atlanta VA Research Safety/ Biosafety, 2024-10-09
- Infection Control: Bloodborne Pathogens and TB
- Privacy and HIPAA Training
- VA Privacy and Information Security Awareness and Rules of Behavior
Training Competencies And Skills
- Recruitment and Screening
- Project Management
- Data Entry
- Study Protocol Compliance
- Good Clinical Practice
- Analytical Methods
- Phlebotomy
- Data Collection
- Data Analysis
- REDCap
- Clinical Trials
- Regulatory Documents
- Organizational Development
- Training of Staff
- Quality Assurance
- IRB Administration
- Case Report Development
- HIPAA Compliance
- Project Planning
- Phlebotomy Certified
- Basic Life Support (BLS) Certified – American Red Cross
Clinical Research Experience
- NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
- Effects of 12-weeks of High-intensity Resistance Aerobic Circuit Exercise Training on Epigenetic Aging and Inflammation in Older HIV-infected Veterans
- Assessing the Cost-effectiveness of HIV healthcare in the DoD and the VA (FIT-VET)
- A PROSPECTIVE COHORT STUDY TO ASSESS LONGITUDINAL IMMUNE RESPONSES IN HOSPITALIZED PATIENTS WITH COVID-19 (COPA)
- VA SHIELD: The US Department of Veterans Affairs Science and Health Initiative to Combat Infectious and Emerging Life-Threatening Diseases (VA SHIELD): A Biorepository Addressing National Health Threats
- Feasibility, Acceptability, and Preliminary Efficacy of Off-Label Medications for Alcohol Use Disorder among Patients with HIV: An Open-Label Pilot Study
- The HIV and Alcohol Research center focused on Polypharmacy (HARP)
- Study Coordinator. “Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)”. Protocol: GRADE, NIH (National Institute of Health) 2016-Present
- Study Coordinator: “A Randomized, Placebo-Controlled, Primary Prevention Clinical Trial With Vitamin D In Patients At High Risk For Diabetes (with pre-diabetes)”. Protocol: D2d, Amylin Pharmaceuticals, 2017-2018.
- Study Coordinator: “A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older”. Protocol: B5091007, Pfizer, 2017 to Present
- Study Coordinator: “A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus”. Protocol: BCB109, Amylin Pharmaceuticals, 2016 to 2017
- Study Coordinator: “A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52 Week Treatment Period in Subjects with Moderate to Severe COPD”. Protocol: PT010005, Pearl Therapeutics, 2015
- Study Coordinator: “A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003 and PT009 Compared with Symbicort Turbohaler as an Active Control in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease”. Protocol: PT010006, Pearl Therapeutics, 2015
- Study Coordinator: “A Randomized, Double-Blind, Parallel-Group, 52-Week, Chronic-Dosing, Multi-Center Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease”. Protocol: PT010008, Pearl Therapeutics, 2015
- Study Coordinator: “A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain” Protocol: 14-181-07, Nektar Therapeutics, 2015-2016
- Study Coordinator: “A Phase 3 Multicenter, Open-Label, 52-Week Study To Evaluate the Long-Term Safety and Tolerability of NKTR-181 in Subjects With Moderate to Severe Chronic Low Back Pain or Chronic Non-Cancer Pain”. Protocol: 14-181-08, Nektar Therapeutics, 2015-2016
- Study Coordinator: “A Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of Bococizumab (PF-04950615), in Reducing The Occurrence of Major Cardiovascular Events in High Risk Subjects-Spire 1”. Protocol: B1481022, Pfizer, 2015
- Study Coordinator: “A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)”. Protocol: SP304203-04, Synergy Pharmaceuticals, 2015
- Study Coordinator: “A long-term, Randomized, Double-Blind, Extension Study Of The Safety, Tolerability, And Efficacy Of Aclidinium Bromide At Two Dose Levels When Administered To Patients With Moderate To Severe Chronic Obstructive Pulmonary Disease”. Protocol: LAS-MD-36, Forest Research Institute, 2009
- Study Coordinator: “Efficacy and Safety of Aclidinium Bromide at Two Dose Levels (200ug Twice Daily, 400ug Twice daily) VS. Placebo When Administered To Patients With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD)”. Protocol: LAS-MD-33, Forest Research Institute, 2009
- Study Coordinator: “A Randomized Study of Stopping Treatment at 24 Weeks or Continuing Treatment to 48 Weeks in Treatment-Naïve Subjects with Genotype 1 Chronic Hepatitis C who Achieve and Extended Rapid Viral Response (eRVR) While Receiving Telaprevir, Peginterferon Alfa2a (Pegasys) and Ribavirin (Copegus)”. Protocol: VX08-950-111, Vertex Pharmaceuticals Incorporated 2008-2009
- Study Coordinator: “A Phase 3, Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin”. Protocol: P05101, Schering-Plough Research Institute 2008-2009
- Study Coordinator: “A Phase 3, Safety and Efficacy Study of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1”. Protocol P05216, Schering-Plough Research Institute 2008-2009
- Study Coordinator: “Randomized, Placebo-Controlled, Multi-Centre Study To Assess The Efficacy and Safety Of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus (HCV) Infection Who Are Otherwise Eligible To Initiate Antiviral Therapy (Peginterferon alfa-2a plus Ribavirin)”. Protocol TPL103922, GlaxoSmithKline 2008
- Study Coordinator: “Comparison Of Different Treatment Regimens In Patients With Stage 1-2 Type C Hepatic Encephalopathy: AST-120 vs Lactulose”. Protocol AST015-00, Ocera Therapeutics 2008
- Study Coordinator: “A Comparative Study Of Chronic Hepatitis B Subjects Treated With Entecavir Plus Tenofovir Combination Therapy VS Entecavir Monotherapy In Adults Who Are Treatment Naïve To Nucleosides And Nucleotides: The BE-LOW Study”. Protocol AI463-110, Bristol Myers Squibb 2008
- Study Coordinator: “A Phase 2, Randomized, Open-Label Study Of The Safety, Antiviral Activity, And Pharmacokinetics of HCV-796 Administered In Combination With PegInterferon Alfa 2b (Peg Intron) Plus Ribavirin (Rebetol) Versus Peg-Intron Plus Rebetol In Subjects With Hepatitis C Virus Genotype 1 Infection”. Protocol 3173A1-200-US, Wyeth Research 2007-2008
- Study Coordinator: “A Phase 3, Randomized, Multi-Center Study To Evaluate The Efficacy and Safety of Albumin Interferon Alfa 2-2b In Combination With Ribavirin Compared With Peginterferon Alfa-2a In Combination With Ribavirin In Interferon Alfa Naïve Subjects With Chronic Hepatitis C Genotype 2 Or 3. Protocol HGS1008-C1067, Human Genome Sciences, Inc 2007-2008
- Study Coordinator: “A Phase 3, Randomized, Multi-Center Study To Evaluate The Efficacy And Safety Of Albumin Interferon Alfa-2b In Combination With Ribavirin Compared With Peginterferon Alfa-2a In Combination With Ribavirin In Interferon Alfa Naïve Subjects With Chronic Hepatitis C Genotype 1. Protocol HGS1008-1060, Human Genome Sciences, Inc 2007-2008
- Study Coordinator: “A Safety and Efficacy Study Of SCH503034 In Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1”. Protocol P03523, Schering-Plough Research Institute 2007-2008
- Study Coordinator:” A Double-Blind, Randomized, Placebo-Controlled MultiCenter, Phase 3, Parallel Dose-Ranging Study To Assess The Antifibrotic Activity Of G1262570 In Chronic Hepatitis C Subjects With Hepatic Fibrosis Who Have Failed Prior Antiviral Therapy”. Protocol: FBX104114, GlaxoSmithKline 2007
- Study Coordinator: “Analysis Of Hepatitis C Viral Kinetics And Viramidine Pharmacokinetics Utilizing Two Treatment Regimens In Therapy-Naïve Patients With Chronic Hepatitis C”. Protocol RNA003142-202, Valeant Research And Development 2007
- Study Coordinator: “A Phase 3, Multicenter Study Evaluating The Efficacy And Safety Of Botulinum Toxin Type A Purified Neurotoxin Complex As Headache Prophylaxis In Migraine Patients (18-65 years of age) With 15 Or More Headache Days Per 4-Week period In A 24 Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed By A 32-Week Open Label Extension Phase”. Protocol 191622-080, Allergan 2006
- Study Coordinator: “A Randomized, Double-Blind, Single Migraine Attack, Placebo-Controlled, Parallel-Group Multicenter Study To Evaluate The Efficacy And Tolerability Of Trexima (sumatriptansuccinate/naproxen sodium) Tablets VS Placebo When Administered During The Mild Pain Phase Of Menstrual Migraine In Women With Dysmenorrhea”. Protocol TRX105850, GlaxoSmithKline 2006
- Study Coordinator: “Divalproex Sodium Extended-Release For Migraine Propylaxis In Adolescents: An Open-Label, Long Term Safety Study”. Protocol M03-648, Abbott Laboratories 2005-2006
- Study Coordinator: “A Phase 3, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Assess The Efficacy And Safety Of Provigil (Modafinil) Treatment (100, 200 and 400mg/day) In Children And Adolescents With Excessive Sleepiness Associated With Narcolepsy”. Protocol C1538/3027/NA/MN, Cephalon 2005-2006
- Study Coordinator: “A Phase 3, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study To Assess The Efficacy And Safety Of Provigil (Modafinil) Treatment (100, 200 and 400mg/day) In Children And Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome”. Protocol C1538/3028/AP/MN, Cephalon 2005-2006
- Study Coordinator: “A One Year Open-Label, Flexible-Dosing Extension Study To Assess The safety And Continued Effectiveness Of Provigil (Modafinil) Treatment In Children And Adolescents With Excessive Sleepiness Associated With Narcolepsy Or Obstructive Sleep Apnea/Hypopnea Syndrome”. Protocol C1538/3029/ES/MN, Cephalon 2005-2006
- Study Coordinator: “A Short-Term (8 Week) Open-Label Study, Followed By A Long Term Evaluation, To Assess Patient Reported Outcomes With Armodafinil Treatment (150 to 250mg/day) For Excessive Sleepiness In Adults With Narcolepsy Or Obstructive Sleep Apnea/Hypopnea Syndrome”. Protocol 10953/3046/ES/US, Cephalon 2005-2006
- Study Coordinator: “An Open-Label Multi-Center Study Of The Long-Term Safety Of Depakote Sprinkle Capsules In The Treatment Of Partial Seizures”. Protocol M04-714, Abbott Laboratories 2004-2006
- Study Coordinator: “A Multi-Center, Double-Blind, Randomized, Parallel-Group Evaluation Of Lamictal Extended Release Adjunctive Therapy In Subjects With Partial Seizures”. Protocol LAM100034, GlaxoSmithKline 2004-2006
- Study Coordinator: “A Multi-Center, Double-Blind, Randomized, Parallel-Group Evaluation Of Lamictal Extended Release Adjunctive Therapy In Subjects With Primary Generalized Tonic-Clonic Seizures”. Protocol LAM100036, GlaxoSmithKline 2004-2006
- Study Coordinator: “A Double-Blind, Multicenter, Randomized, Placebo-Controlled, Single Dose Study To Evaluate The Safety And Efficacy Of Trexima In The Acute Treatment Of Migraine Headaches”. Protocol MT400-302, Pozen 2004-2005
- Study Coordinator: “A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Attack Evaluation Of The Efficacy And Tolerability Of Trexima Tablets VS Placebo When Administered During The Mild Pain Phase Of A Migraine”. Protocol 101999, GlaxoSmithKline 2004-2005
- Study Coordinator: “Adult Early Migraine Intervention Study: Efficacy And Safety Of Axert (Almotriptan) Versus Placebo For The Acute Treatment Of Migraine Headache When Administered Within Once Hours Of Migraine Onset”. Protocol CAPSS-316, Ortho McNeil 2004-2005
- Study Coordinator: “A 1-Year, Open-Label, Flexible-Dosage Study To Evaluate The Safety And Continued Efficacy Of Modafinil (Film-Coated Tablet Formulation) In Children And Adolescents With Attention-Deficit/Hyperactivity Disorder”. Protocol C1538d/312/AD/US, Cephalon 2003-2005
Personal Information
Title: Clinical Research Coordinator
Timeline
Clinical Research Coordinator
FAVER
05.2016 - Current
Clinical Research Coordinator
FAVER
05.2016 - Current
Clinical Research Coordinator
In-Quest Medical Research, LLC
11.2015 - 04.2016
Clinical Research Coordinator
In-Quest Medical Research, LLC
11.2015 - 04.2016
Clinical Research Coordinator
Child Neurology Associates, PC
07.2004 - 12.2006
Clinical Research Coordinator
Child Neurology Associates, PC
07.2004 - 12.2006
Scheduling/Medical Assistant
Child Neurology Associates, PC
07.2002 - 07.2004
Bachelor of Arts - Sociology, Psychology
Piedmont College